Grazoprevir-elbasvir combo shows high cure rate for patients with chronic HCV
Once-daily oral grazoprevir/elbasvir combination therapy, taken without interferon or ribavirin for 12 weeks, demonstrated high sustained virologic response rates for treatment-naïve patients with cirrhotic or non-cirrhotic ...
Apr 24, 2015
0
9